Christina Teng Topsoe - Mar 31, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
Mar 31, 2022
Transactions value $
$0
Form type
4
Date filed
4/4/2022, 08:13 PM
Previous filing
Mar 15, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $0 +346 +0.95% $0.00 36.9K Mar 31, 2022 Direct F1
holding IGMS Common Stock 10.4M Mar 31, 2022 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
F2 All shares are held directly by Topsoe Holding A/S (formerly Haldor Topsoe Holding A/S). Jakob Haldor Topsoe, Christina Teng Topsoe, Anne Haugwitz-Hardenberg-Reventlow, Emil Oigaard, Thomas Schleicher and Birgitte Nielsen, members of the board of directors of Topsoe Holding A/S, may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein, if any.